Update on the use of steroids in rheumatoid arthritis.
Reumatol Clin
; 9(5): 297-302, 2013.
Article
em En, Es
| MEDLINE
| ID: mdl-23726772
ABSTRACT
Corticosteroids are a mainstay in the therapy of rheumatoid arthritis (RA). In recent years, a number of high-quality controlled clinical trials have shown their effect as a disease-modifying anti-rheumatic drug (DMARD) and a favourable safety profile in recent-onset RA. Despite this, they are more frequently used as bridge therapy while other DMARDs initiate their action than as true disease-modifying agents. Low-dose corticosteroid use during the first two years of disease slows radiologic damage and reduces the need of biologic therapy aimed at reaching a state of clinical remission in recent-onset RA. Thus, their systematic use in this clinical scenario should be considered.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Artrite Reumatoide
/
Corticosteroides
Limite:
Humans
Idioma:
En
/
Es
Revista:
Reumatol Clin
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
Espanha